Cardiovascular Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/cardiovascular/ The leading site for news and procurement in the pharmaceutical industry Thu, 15 Aug 2024 08:54:13 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.1 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Cardiovascular Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/cardiovascular/ 32 32 Noumed’s Pharmaceutical Manufacturing Facility, Adelaide, Australia https://www.pharmaceutical-technology.com/projects/noumed-pharmaceutical-manufacturing-facility-adelaide-australia/ Thu, 15 Aug 2024 08:54:13 +0000 https://www.pharmaceutical-technology.com/?post_type=projects&p=326319 US judge denies initial attempt by Novartis to block generic Entresto launch https://www.pharmaceutical-technology.com/news/us-judge-denies-initial-attempt-by-novartis-to-block-generic-entresto-launch/ Tue, 13 Aug 2024 16:10:34 +0000 https://www.pharmaceutical-technology.com/news/us-judge-denies-initial-attempt-by-novartis-to-block-generic-entresto-launch/ Bayer set to expand Kerendia’s label in cardiology with Phase III win https://www.pharmaceutical-technology.com/news/bayer-set-to-expand-kerendias-label-in-cardiology-with-phase-iii-win/ Mon, 05 Aug 2024 13:08:42 +0000 https://www.pharmaceutical-technology.com/news/bayer-set-to-expand-kerendias-label-in-cardiology-with-phase-iii-win/ MHRA approves Novo Nordisk’s semaglutide to cut cardiovascular risk https://www.pharmaceutical-technology.com/news/mhra-novo-nordisk-semaglutide-approval/ Wed, 24 Jul 2024 08:20:29 +0000 https://www.pharmaceutical-technology.com/news/mhra-novo-nordisk-semaglutide-approval/ Cardurion closes $260m in Series B to develop cardiovascular pipeline https://www.pharmaceutical-technology.com/news/cardurion-closes-260m-in-series-b-to-develop-cardiovascular-pipeline/ Wed, 17 Jul 2024 14:04:34 +0000 https://www.pharmaceutical-technology.com/news/cardurion-closes-260m-in-series-b-to-develop-cardiovascular-pipeline/ Novo Nordisk’s ocedurenone Phase III flop costs company $816m https://www.pharmaceutical-technology.com/news/novo-nordisk-ocedurenone-flop-816m/ Thu, 27 Jun 2024 09:00:31 +0000 https://www.pharmaceutical-technology.com/uncategorized/novo-nordisk-ocedurenone-flop-816m/ Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio https://www.pharmaceutical-technology.com/news/tectonic-bets-on-gpcr-heart-failure-drug-following-reverse-merger-with-avrobio/ Fri, 21 Jun 2024 14:15:06 +0000 https://www.pharmaceutical-technology.com/news/tectonic-bets-on-gpcr-heart-failure-drug-following-reverse-merger-with-avrobio/ Marea launches with $190m to develop cardiometabolic therapies https://www.pharmaceutical-technology.com/news/marea-launches-cardiometabolic-therapies/ Wed, 19 Jun 2024 10:10:36 +0000 https://www.pharmaceutical-technology.com/news/marea-launches-cardiometabolic-therapies/ AstraZeneca champions early kidney disease diagnosis with modelling data https://www.pharmaceutical-technology.com/news/astrazeneca-champions-early-kidney-disease-diagnosis-with-modelling-data/ Tue, 11 Jun 2024 16:52:55 +0000 https://www.pharmaceutical-technology.com/news/astrazeneca-champions-early-kidney-disease-diagnosis-with-modelling-data/ EC grants orphan medicinal product status to Rocket’s RP-A601 https://www.pharmaceutical-technology.com/news/ec-rocket-pharmaceuticals-rp-a601/ Thu, 30 May 2024 10:23:57 +0000 https://www.pharmaceutical-technology.com/news/ec-rocket-pharmaceuticals-rp-a601/